Technology

Spring Health Proposes Open Industry Benchmark for AI in Mental Health

Published

12 months ago

May 6, 2025

Uniting Experts, Clinicians, Researchers, and Industry to Build a Safer Future for Mental Health AI

NEW YORK, May 6, 2025 /PRNewswire/ — Spring Health, a complete global mental health solution for employers and health plans, today announced a bold initiative with the launch of VERA-MH (Validation of Ethical and Responsible AI in Mental Health)—the first open-source benchmark to evaluate how well AI handles emotionally difficult and sensitive situations.

Modeled after leading frameworks like GAIA (General AI Assistant benchmark), VERA-MH will set a new industry standard for clinical integrity, ethical responsibility, and operational safety in mental health AI. The benchmark will measure AI performance across multi-turn, emotionally complex interactions—where the cost of error can be life-altering.

Mental health is one of the most sensitive frontiers for artificial intelligence. From suicide risk to medication questions to cultural nuance, today’s AI models are not consistently safe, ethical, or clinically aligned. Without a shared standard, companies risk shipping harmful or untrustworthy experiences—and users risk real consequences.

Spring Health will act as a founding contributor, offering early vision and technical leadership, while committing to an independent, multi-stakeholder governance structure. The governance body will include clinicians, ethicists, researchers, and industry experts, selected through a transparent nomination process with strict conflict-of-interest policies. VERA-MH is a multi-year, community-driven effort, designed to produce meaningful technical, clinical, and operational standards—not just principles.

“AI in mental health must meet the highest bar for trust, safety, and human dignity,” said April Koh, CEO of Spring Health. “Early on, the lack of a benchmark was a barrier to developing AI on our own platform. That’s why we’re excited to share our early learnings and collaborate with the mental health and AI communities—because we believe VERA-MH can help the entire field rise to that challenge.”

The benchmark will be open-sourced and developed with input from clinicians, ethicists, AI researchers, and people with lived experience. Spring Health invites organizations across healthcare, AI, academia, and advocacy to join the founding consortium and help shape the future of mental health AI.

Interested collaborators—whether academic, industry, or nonprofit—can contact VERAMH@springhealth.com to learn more.

About Spring Health
Spring Health is a complete global mental health solution for employers and health plans. By integrating products for members, providers, and customers, Spring Health uniquely delivers personalized care for every individual—ranging from digital tools and meditation to coaching, therapy, and medication—ensuring the right care at the right time. Certified by JAMA Network Open and the Validation Institute for demonstrating net savings for customers, Spring Health also equips global business leaders with intelligent technology, real-time insights, and clinical expertise to support diverse and evolving organizational needs.

Today, more than 20 million people worldwide have access to Spring Health. We’re trusted by leading employers, health plans and channel partners, including Adobe, Bumble, General Mills, Moda Health, Wellstar, and Guardian, to drive cultural impact at scale. For more information, please visit https://www.springhealth.com.

Media Contact
springhealth@5wpr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/spring-health-proposes-open-industry-benchmark-for-ai-in-mental-health-302446601.html

SOURCE Spring Health

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

39 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

39 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

39 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated